Nirsevimab is recommended for preventing RSV lower respiratory tract infection in infants younger than one year in their ...

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

According to the NHS, people infected with RSV will typically show symptoms within the first few days of infection. This can ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company’s ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually ...

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

For the first study, published yesterday in JAMA Network Open, Danish researchers used national registry data to assess rates ...